<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>15400</id><no>A032103-NCT05987241</no><status>Open</status><title>MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer</title><secondary_protocol_no>A032103</secondary_protocol_no><nct_id>NCT05987241</nct_id><sponsor_type>National</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II/III</phase><disease_site>Urinary Bladder</disease_site><PI>Simon, Nicholas</PI><institution>Georgetown University Medical Center : Jamie Manganti, Beth Mekonen; Lombardi Comprehensive Cancer Center : Jamie Manganti, Beth Mekonen; Medstar Washington Hospital Center : Win Phyu</institution><oncology_group>Genito-urinary<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>16061</contact_id><item_description>Beth Mekonen</item_description><js_safe_str>Beth Mekonen</js_safe_str><email>bam159@georgetown.edu</email></item><item><contact_id>16158</contact_id><item_description>Win Phyu</item_description><js_safe_str>Win Phyu</js_safe_str><email>win.phyu@medstar.net</email></item><item><contact_id>16801</contact_id><item_description>Jamie Manganti</item_description><js_safe_str>Jamie Manganti</js_safe_str><email>jm3821@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>